Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to obtain long-term data on effects, safety and tolerability in routine medical
practice and to investigate the potential of telmisartan to prevent secondary organ damage
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan Telmisartan, hydrochlorothiazide drug combination